As discussed above, deregulation of these signaling cascades by mutation or overexpression of several receptors leads to aberrant activation of these intracellular cascades. the various components of the PI3K and Akt pathway in different types of cancer both and gene. Evidence suggests that p85 is the most abundantly expressed regulatory isoform of PI3K, and p55 and p50 are two minor alternative splicing isoforms4,5. The p110 subunit is encoded by the gene and has three isoforms: , , and . The p110 isoform is the most common and important subunit in PI3K and the components of p110 include an N-terminal p85-binding domain (p85BD), a RAS binding domain (RBD), a protein-kinase-C homology-2 (C2) domain, a helical domain, and a C-terminal kinase domain. Class IB PI3K comprises p101 regulatory and p110 catalytic subunits, which feature similar activity6. These two types of enzymes catalyze ITIC-4F the phosphorylation of ITIC-4F lipid substrate phosphatidylinositols such as PI(4)P and PI(4,5)P2 at their D3 position and the resulting product is PI-3,4,5-P3, which activates downstream signaling pathways through the phosphorylation of several kinases. These kinases include Akt and 3-phosphoinositide-dependent kinase (PDK) and appear to be involved in the regulation of cellular responses varying with the cell types and stimuli studied7. The role of receptors in PI3K deregulation The class I PI3K is activated by receptor tyrosine kinases (RTK). RTK activation results in the association of PI3K with the receptor through one or two SH2 domains in the adaptor unit binding to phosphotyrosine consensus motifs. Previously published data suggest that allosteric activation of the catalytic subunit of PI3K in this manner leads to PI-3,4,5-P3 production within a few seconds. The effect of polyphosphoinositide on cells is mediated through specific binding to at least two distinct protein-lipid binding domains, such as Fab-1, YGL023, Vps27, and EEA1 domain (FYVE) and pleckstrin homology (PH) domains. Proteins containing the latter domain are critical mediators for PI3K class IA-induced signaling. The protein serine/threonine kinase 30-phosphoinositide-dependent kinase1 (PDK1) and Akt/PKB are both critical for the transforming effects ITIC-4F of deregulated PI3K activity. Ligand-dependent activation of protein tyrosine kinase receptors and receptors coupled with either G-proteins or integrins results in PI3K activation. Such activation may also occur independently of the receptor, as is the case ITIC-4F in cells expressing constitutively active Ras. PI3K activation can also occur in the presence of some selected receptor families (studies using p53-deficient mice and LID mice with colon adenocarcinomas demonstrated that IGF-I deficiency reduces tumor growth. In addition to the growth-promoting effects of insulin and IGF-I, IGF-II overexpression has also been observed to play a role in tumor development. IGF-II is produced in the liver and many other tissues in adult humans. In contrast, in rats IGF-II ITIC-4F expression decreases in postnatal life and is only expressed to a significant degree in the adult rat brain. In normal conditions, IGF-II expression is controlled by the paternal chromosome under the control of the differentially methylated region (DMR) associated with the H19 gene located upstream on chromosome 11. A loss of imprinting resulting from the methylation of the DMR on the maternal allele leads to overexpression of IGF-II, which has been observed in many tumor GLI1 types14. Insulin-like growth factor binding proteins (IGFBPs) play an important role in the stabilization of IGF-I and -II. Among the 6 IGFBP proteins, named IGFBP-1 to IGFBP-6, IGFBP-3 is the most predominant. These binding of proteins increase the circulating half-lives of IGF-I and IGF-II and protect them from further degradation. The main disadvantage of the IGFBPs is that although they increase the stability of IGF, they in turn reduce the availability of IGF for receptor binding14. IGFR consists of two isoforms: IGF-1R and IGF-2R. These two isoforms, along with the insulin receptors, form the hybrid receptors IGF-1R/IR-A and IGF-1R/IR-B. All of the IGF receptors have significant homology, thus resulting in structural similarity and the possibility.